What are the top holdings of quant Healthcare Fund?

quant Healthcare Fund holds 11 equity positions; the largest is HFCL Limited at 9.55% of the portfolio, as on May 2026. Information only, not investment advice.

How concentrated is quant Healthcare Fund?

Its single largest equity position is HFCL Limited, at 9.55% of the fund's disclosed portfolio.

As of when is this quant Healthcare Fund portfolio?

Portfolio as on May 2026, taken from Quant Mutual Fund's public monthly portfolio disclosure.

What is the NAV of quant Healthcare Fund?

The latest NAV (Net Asset Value) of quant Healthcare Fund is ₹17.83 per unit, as on May 2026, sourced from AMFI's public scheme data. NAV changes daily with market movements. Information only, not investment advice.

Who manages quant Healthcare Fund?

quant Healthcare Fund is managed by Sanjeev Sharma; Ankit A. Pande; Sandeep Tandon; Varun Pattani; Sameer Kate; Ayusha Kumbhat; Yug Tibrewal, as per AMFI's public disclosure. Fund manager details sourced from Kuvera/AMFI data. Information only, not investment advice.

What is the expense ratio of quant Healthcare Fund?

quant Healthcare Fund has a Total Expense Ratio (TER) of 0.85% p.a., as disclosed to AMFI. The TER is the annual cost of running the fund, deducted daily from the NAV. A lower TER means more of the fund's return flows to investors. Information only, not investment advice.

What is the 1-year NAV return of quant Healthcare Fund?

quant Healthcare Fund's NAV moved from ₹16.05 (Jul 2025) to ₹17.83 (Jul 2026), a change of 11.1% over approximately one year. NAV data sourced from AMFI. Past performance is not indicative of future returns. Information only, not investment advice.

What is the Sharpe ratio of quant Healthcare Fund?

Based on roughly 11 months of NAV history, quant Healthcare Fund has an annualized return of about 12.1% with 14.3% annualized volatility, giving a Sharpe ratio of 0.39 (assuming a 6.5% risk-free rate). A higher Sharpe ratio means more return per unit of risk taken. Past performance is not indicative of future returns.

:root{--background:#08090c;--background-2:#0c0e12;--foreground:#e9eaec;--card:#0e1014;--card-foreground:#e9eaec;--muted:#15171d;--muted-foreground:#9298a4;--border:#1e2129;--border-strong:#2b2f3a;--primary:#10b981;--primary-foreground:#052e22;--ring:#34d399;--positive:#34d399;--negative:#fb7185;--brand-600:#34d399}

WhoHolds

Smart-Beta / FactorVery High RiskQuant Mutual Fund

quant Healthcare Fund

Portfolio as on May 2026 · 11 equity positions

Equity positions

Equity value

₹259 Cr

Top holding

9.55%

HFCL Limited

NAV per unit

₹17.83

May 2026

Expense ratio

0.85% p.a.

Fund manager

Sanjeev Sharma; Ankit A. Pande; Sandeep Tandon; Varun Pattani; Sameer Kate; Ayusha Kumbhat; Yug Tibrewal

Own another fund too? See how much they overlap →

Portfolio Structure & Asset Allocation Analysis

quant Healthcare Fund is a Smart-Beta / Factor scheme managed by Quant MF Mutual Fund. As of disclosures dated May 2026, the scheme holds 11 equity positions with an estimated equity AUM of ₹₹259 Cr. The portfolio is anchored by its top conviction bet on HFCL, which commands a weight of 9.55%of the fund's total assets.

From a sector allocation perspective, the fund managers have concentrated their largest bet on Pharmaceuticals & Biotechnology, representing 55.73% of the equity portfolio. This is followed by Telecom - Services (13.75%) and Food Products (12.58%). Under SEBI's guidelines and based on its underlying assets, this scheme carries a Very High Risk risk classification.

Diversification Warning: High sector concentration can increase volatility. If you hold index heavyweights like HFCL directly in your stock portfolio, adding this fund will compound your exposure to them. Ensure your holdings are balanced and check overlap with your existing schemes using our Mutual Fund Overlap Tool.

NAV history

₹17.83 per unit +11.1% vs Jul '25

Last 365 days · daily NAV from AMFI · quant Healthcare Fund

Performance & risk

Annualized return

+12.1%

Volatility

14.3%

Sharpe ratio

0.39

Based on ~11 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio assumes a 6.5% risk-free rate. Past performance does not guarantee future returns — not investment advice.

Sector allocation

11stocks

Pharmaceuticals & Biotechnology56%
Telecom - Services14%
Food Products13%
Healthcare Services13%
Insurance5%

Top holdings

Top 10 holdings make up 67.5% of the portfolio · top 5 = 43.3%.

11 stocks

#
1	HFCLTelecom - Services₹35.58 Cr	9.55%	₹35.58 Cr	19.77 L
2	Zydus WellnessFood Products₹32.54 Cr	8.74%	₹32.54 Cr	6.42 L
3	Aster DM HealthcareHealthcare Services₹32.53 Cr	8.73%	₹32.53 Cr	4.47 L
4	Anthem BiosciencesPharmaceuticals & Biotechnology₹32.25 Cr	8.66%	₹32.25 Cr	4.24 L
5	SMS PharmaceuticalsPharmaceuticals & Biotechnology₹28.53 Cr	7.66%	₹28.53 Cr	7.73 L
6	Alivus Life SciencesPharmaceuticals & Biotechnology₹26.00 Cr	6.98%	₹26.00 Cr	2.46 L
7	PfizerPharmaceuticals & Biotechnology₹22.05 Cr	5.92%	₹22.05 Cr	48.0K
8	Aurobindo PharmaPharmaceuticals & Biotechnology₹18.43 Cr	4.95%	₹18.43 Cr	1.29 L
9	HDFC Life Insurance CompanyInsurance₹13.89 Cr	3.73%	₹13.89 Cr	2.34 L
10	Strides Pharma SciencePharmaceuticals & Biotechnology₹9.78 Cr	2.63%	₹9.78 Cr	88.0K
11	GlaxoSmithKline PharmaceuticalsPharmaceuticals & Biotechnology₹7.18 Cr	1.93%	₹7.18 Cr	32.5K